by Haja Mo October 7, 2024 Business After supply chain disruptions that made critical medicines scarce, a federal effort is underway to ensure domestic stocks of pharmaceutical ingredients. Previous Story How a Lobbying Group Is Arguing That Big Tech Protects Free Speech Next Story Oil Prices Rise as Mideast Crisis Intensifies